Regeneron Pharmaceuticals Inc

NASDAQ: REGN
$829.43
+$0.59 (+0.1%)
Closing Price on November 5, 2024

REGN Stock Chart and Intraday Price

REGN Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 107,876.29M USD
Shares Outstanding 107,944,000
Regeneron Pharmaceuticals Inc is a biotech firm based in Tarrytown, New York, known for its innovative approach to developing and commercializing medicines for a variety of diseases. The company's portfolio includes treatments for eye conditions like wet age-related macular degeneration, skin diseases such as atopic dermatitis, and other serious ailments including asthma, cardiovascular disease, and certain cancers. Regeneron is also notable for its contributions to infectious disease treatments, including a therapy for COVID-19 and the Ebola virus. Founded in 1988, Regeneron stands out for its commitment to addressing unmet medical needs.

REGN Articles

Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of these picks. Whether we’re...
Thursday's top analyst upgrades and downgrades included DocuSign, Etsy, Guardant Health, International Paper, Johnson Controls, Kosmos Energy, Levi Strauss, Snowflake, Tesla, Topgolf Calloway Brands,...
Tuesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Boston Scientific, Ciena, CrowdStrike, Emerson Electric, Kimco Realty, Nike, NovoCure and Zimmer Biomet.
Thursday's top analyst upgrades and downgrades included Brixmor Property, CAVA, Chevron, GE Healthcare Technologies, Keurig Dr Pepper, News Corp, PACCAR, Permian Resources, Pioneer Natural Resources,...
Thursday's top analyst upgrades and downgrades included Amazon.com, Bristol-Myers Squibb, Coherent, Deere, GoDaddy, Pinterest, Rexford Industrial Realty, Salesforce, Uber Technologies, Vale,...
Friday's top analyst upgrades and downgrades included Alcoa, Archer Daniels Midland, Caterpillar, Dow, Expedia, Kellogg, PagSeguro Digital, Sea, Tesla, Tripadvisor and Walmart.
Thursday's top analyst upgrades and downgrades included America Movil, Avis Budget, Box, Chevron, Coty, Five9, Regeneron Pharmaceuticals, SeaWorld Entertainment, Twilio, Viking Therapeutics and Xylem.
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Amcor, Caesars Entertainment, CarMax, Chewy, Marriott International, Microsoft, Molson Coors Beverage, NXP...
Tuesday's top analyst upgrades and downgrades included Alphabet, Caterpillar, Corning, Digital Realty Trust, Dish Network, KeyCorp, Nvidia, Pinterest, Roku, Tesla and Wynn Resorts.
Monday's top analyst upgrades and downgrades included Altria, Block, Coinbase Global, Deere, First Horizon, KB Home, Pfizer, PNC Financial Services, RingCentral, Uber Technologies znd Zoom Video...
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amazon.com, Colgate-Palmolive, Kohl's, Lockheed Martin, Lyft, Macy's, Meta Platforms, Okta, Shopify, Tesla and Uber...
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Global Payments, Lululemon Athletica, Mastercard, Mosaic, Netflix, Nordstrom, Pinterest, Travelers and Truist Financial.
Wednesday’s additional top analyst upgrades and downgrades were on Ally Financial, Baker Hughes, Biohaven, Biogen, Bumble, Canopy Growth, Corning, Discover Financial Services, Match, Roku and more.
Monday’s additional top analyst upgrades and downgrades were on Albertsons Companies, Apple, Clorox, Cloudflare, Fox, Kroger, Opendoor Technologies, Petroleo Brasileiro and more.
Monday's top analyst upgrades and downgrades included Adobe, Carvana, Goldman Sachs, Hudson Pacific Properties, Moderna, Take-Two Interactive Software and T-Mobile.